Opava, Czechia

Kvetoslava Benesova


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2000-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kvetoslava Benesova: Innovator in Flavanolignan Preparations

Introduction

Kvetoslava Benesova is a notable inventor based in Opava, Czech Republic. She has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the solubility of flavanolignan preparations. With a total of 3 patents to her name, her work addresses critical challenges in drug delivery systems.

Latest Patents

One of her latest patents focuses on "Increased solubility flavanolignan preparations." In this innovation, Kvetoslava and her team devised novel approaches for preparing flavanolignan compositions that are enhanced in solubility and substantially free of toxic contaminants. These methods utilize spray drying or lyophilizing techniques to dry a diluted preparation of flavanolignan, effectively avoiding the use of toxic excipients and carriers commonly employed in existing methods.

Another significant patent is related to a "Cyclosporin formulation." This invention provides therapeutic compositions that ensure high bioavailability of active ingredients from the cyclosporin group. It allows for concentrations in dosage forms that exceed 10%, thereby improving the efficacy of the treatment.

Career Highlights

Throughout her career, Kvetoslava has worked with reputable companies such as Galena AS and Ivax Pharmaceuticals S.r.o. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations and formulations.

Collaborations

Kvetoslava has collaborated with notable professionals in her field, including Milan Stuchlik and Alexandr Jegorov. These partnerships have further enriched her research and development efforts.

Conclusion

Kvetoslava Benesova stands out as an innovative inventor whose work in flavanolignan preparations and cyclosporin formulations has the potential to significantly impact the pharmaceutical industry. Her contributions reflect a commitment to improving drug solubility and bioavailability, paving the way for more effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…